BindingDB logo
myBDB logout

Search by WIPO Patent


WIPO: (prefix with "WO" like WO2006061714)
WIPODataCompoundsHGNC*WIPO TitleOrganizationDepositionDownloads
WO2022079616 44 29 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS NOVARTIS AG 05/24/222D 3D TSV
WO2022081973 137 71 PHOSPHOLIPID COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. 05/24/222D 3D TSV
WO2022081807 252 229 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. 05/24/222D 3D TSV
WO2022081842 96 68 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. 05/24/222D 3D TSV
WO2022086828 792 294 HGNC:8977 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 05/24/222D 3D TSV
WO2022076764 166 83 HGNC:3827 HGNC:3826 AMINOIMIDAZOLE FPR2 AGONISTS BRISTOL-MYERS SQUIBB COMPANY 05/02/222D 3D TSV
WO2022064009 299 172 CYCLIN-DEPENDENT KINASE 7 (CDK7) NON-COVALENT INHIBITORS JANSSEN PHARMACEUTICA NV 05/02/222D 3D TSV
WO2022070068 29 25 HGNC:2867 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. 05/02/222D 3D TSV
WO2022070069 6 6 HGNC:2867 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. 05/02/222D 3D TSV
WO2022070071 8 8 HGNC:2867 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. 05/02/222D 3D TSV
WO2022076495 144 141 HGNC:16940 PREPARATION OF BENZIMIDAZOLONE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS MERCK SHARP & DOHME CORP. 05/02/222D 3D TSV
WO2022076496 170 168 HGNC:16940 PREPARATION OF OXINDOLE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS MERCK SHARP & DOHME CORP. 05/02/222D 3D TSV
WO2022043374 136 100 Aminocarbamoyl compounds for the treatment of viral infections F. Hoffmann-La Roche Ag 03/30/222D 3D TSV
WO2021219089 190 178 Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections Insilico Medicine Ip Limited 01/27/222D 3D TSV
WO2021205290 52 44 Compounds and method of treating covid-19 Pfizer Inc. 01/13/222D 3D TSV
WO2021205298 15 3 Compounds and methods for the treatment of covid-19 Pfizer Inc. 01/13/222D 3D TSV
WO2021250648 170 94 Nitrile-containing antiviral compounds Pfizer Inc. 01/13/222D 3D TSV
WO2006061714 12 12 Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis Pfizer Inc. 01/31/212D 3D TSV
WO2005113580 101 61 Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis Pfizer Inc. 10/17/202D 3D TSV
*for human-derived proteins